What is Fertility Focus?
Fertility Focus operates at the intersection of medical technology and consumer health, specializing in advanced cycle monitoring and ovulation prediction. The company's flagship OvuSense family of products, including OvuCore and OvuFirst, utilizes patented sensor technology to provide high-accuracy data for women navigating various stages of their reproductive health. By offering clinical-grade insights for home use, the firm addresses significant gaps in traditional fertility tracking, particularly for individuals managing conditions such as Polycystic Ovary Syndrome (PCOS).
Beyond its hardware offerings, the company maintains a robust community-driven ecosystem, including the largest closed support group for women with PCOS. This dual approach—combining high-precision diagnostic hardware with active patient support—positions Fertility Focus as a leader in the FemTech landscape, effectively bridging the gap between clinical treatment and personal health management.
How much funding has Fertility Focus raised?
Fertility Focus has raised a total of $2.7M across 1 funding round:
Series A
$2.7M
Series A (2019): $2.7M with participation from Foresight Group LLP and Coutts Investment Club
Key Investors in Fertility Focus
Foresight Group LLP
A leading independent infrastructure and private equity investment manager established in 1984, focusing on sustainable growth and long-term value creation.
Coutts Investment Club
A historic private bank and wealth management institution providing sophisticated financial advisory and investment services to high-net-worth clients.
What's next for Fertility Focus?
With the recent influx of capital, Fertility Focus is poised to transition from a specialized developer to a dominant player in the global reproductive health market. The strategic roadmap likely involves the expansion of its remote monitoring capabilities, particularly for clinical settings where OvuSense Pro is already demonstrating utility in treatment screening. Furthermore, the company is expected to invest heavily in R&D to refine its sensor technology and broaden its diagnostic portfolio.
As the firm scales, it will likely focus on deepening its integration with healthcare providers, ensuring that its data-driven insights become a standard component of fertility treatment protocols. By maintaining its commitment to accuracy and patient-centric design, Fertility Focus is well-equipped to navigate the complexities of the medical device industry while continuing to provide essential support to its growing user base.
